Comparison of the capture-recapture method and seroprevalence survey for estimation of COVID-19 prevalence in the Islamic Republic of Iran

Reliable estimation of prevalence is important for monitoring and evaluation of COVID-19 prevention programmes among at-risk populations. We compared the capture-recapture method with a seroprevalence survey for accurate estimation of the prevalence of COVID-19 during a 1-year period in Guilan Provi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eastern Mediterranean health journal 2023-02, Vol.29 (2), p.126-131
Hauptverfasser: Davoudi Kiakalayeh, Ali, Rahbar Taramsari, Morteza, Mohammadi, Reza, Davoudi Kiakalayeh, Sajad, Kavakpour, Hassan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Reliable estimation of prevalence is important for monitoring and evaluation of COVID-19 prevention programmes among at-risk populations. We compared the capture-recapture method with a seroprevalence survey for accurate estimation of the prevalence of COVID-19 during a 1-year period in Guilan Province, northern Islamic Republic of Iran. We used the capture-recapture method to estimate the prevalence of COVID-19. Records from the primary care registry system and the Medical Care Monitoring Center were compared, using 4 matching approaches based on combinations of the following variables: name, age, gender, date of death, positive or negative cases, and alive or dead cases. The estimated prevalence of COVID-19 in the study population from the beginning of the pandemic in February 2020 until the end of January 2021 was 16.2-19.8%, depending on the matching approach used, which was lower than in previous studies. The capture-recapture method may provide better accuracy than seroprevalence surveys in measuring the prevalence of COVID-19. This method may also reduce the bias in the estimation of prevalence and correct the misconception of policymakers about seroprevalence survey results.
ISSN:1020-3397
1687-1634
DOI:10.26719/emhj.23.010